These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9108811)

  • 1. A double-blind study of long-term treatment with sertraline or fluvoxamine for prevention of highly recurrent unipolar depression.
    Franchini L; Gasperini M; Perez J; Smeraldi E; Zanardi R
    J Clin Psychiatry; 1997 Mar; 58(3):104-7. PubMed ID: 9108811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors.
    Grimsley SR; Jann MW
    Clin Pharm; 1992 Nov; 11(11):930-57. PubMed ID: 1464219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, placebo-controlled trial of sertraline for prophylactic treatment of highly recurrent major depressive disorder.
    Lépine JP; Caillard V; Bisserbe JC; Troy S; Hotton JM; Boyer P
    Am J Psychiatry; 2004 May; 161(5):836-42. PubMed ID: 15121648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sertraline versus fluvoxamine in the treatment of elderly patients with major depression: a double-blind, randomized trial.
    Rossini D; Serretti A; Franchini L; Mandelli L; Smeraldi E; De Ronchi D; Zanardi R
    J Clin Psychopharmacol; 2005 Oct; 25(5):471-5. PubMed ID: 16160624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression.
    Lydiard RB; Stahl SM; Hertzman M; Harrison WM
    J Clin Psychiatry; 1997 Nov; 58(11):484-91. PubMed ID: 9413414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression.
    Bennie EH; Mullin JM; Martindale JJ
    J Clin Psychiatry; 1995 Jun; 56(6):229-37. PubMed ID: 7775364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression.
    Zanardi R; Franchini L; Gasperini M; Perez J; Smeraldi E
    Am J Psychiatry; 1996 Dec; 153(12):1631-3. PubMed ID: 8942464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of sertraline in the management of depression.
    Shelton RC
    Clin Ther; 1994; 16(5):768-82; discussion 767. PubMed ID: 7859236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term treatment of psychotic (delusional) depression with fluvoxamine: an open pilot study.
    Zanardi R; Franchini L; Gasperini M; Smeraldi E; Perez J
    Int Clin Psychopharmacol; 1997 Jul; 12(4):195-7. PubMed ID: 9347379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction.
    Feiger A; Kiev A; Shrivastava RK; Wisselink PG; Wilcox CS
    J Clin Psychiatry; 1996; 57 Suppl 2():53-62. PubMed ID: 8626364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia.
    Thase ME; Fava M; Halbreich U; Kocsis JH; Koran L; Davidson J; Rosenbaum J; Harrison W
    Arch Gen Psychiatry; 1996 Sep; 53(9):777-84. PubMed ID: 8792754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venlafaxine versus fluvoxamine in the treatment of delusional depression: a pilot double-blind controlled study.
    Zanardi R; Franchini L; Serretti A; Perez J; Smeraldi E
    J Clin Psychiatry; 2000 Jan; 61(1):26-9. PubMed ID: 10695642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to an open trial of a second SSRI in major depression.
    Joffe RT; Levitt AJ; Sokolov ST; Young LT
    J Clin Psychiatry; 1996 Mar; 57(3):114-5. PubMed ID: 8617695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.
    Rosenbaum JF; Fava M; Hoog SL; Ascroft RC; Krebs WB
    Biol Psychiatry; 1998 Jul; 44(2):77-87. PubMed ID: 9646889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-response efficacy of paroxetine in preventing depressive recurrences: a randomized, double-blind study.
    Franchini L; Gasperini M; Perez J; Smeraldi E; Zanardi R
    J Clin Psychiatry; 1998 May; 59(5):229-32. PubMed ID: 9632032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis.
    Greist JH; Jefferson JW; Kobak KA; Katzelnick DJ; Serlin RC
    Arch Gen Psychiatry; 1995 Jan; 52(1):53-60. PubMed ID: 7811162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of serotonin selective reuptake inhibitors in geriatric depression.
    Newhouse PA
    J Clin Psychiatry; 1996; 57 Suppl 5():12-22. PubMed ID: 8647788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind study of the efficacy and safety of sertraline versus fluoxetine in major depression.
    Aguglia E; Casacchia M; Cassano GB; Faravelli C; Ferrari G; Giordano P; Pancheri P; Ravizza L; Trabucchi M; Bolino F
    Int Clin Psychopharmacol; 1993; 8(3):197-202. PubMed ID: 8263318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression.
    Murray V; von Arbin M; Bartfai A; Berggren AL; Landtblom AM; Lundmark J; Näsman P; Olsson JE; Samuelsson M; Terént A; Varelius R; Asberg M; Mårtensson B
    J Clin Psychiatry; 2005 Jun; 66(6):708-16. PubMed ID: 15960563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder.
    Barr LC; Goodman WK; Anand A; McDougle CJ; Price LH
    Am J Psychiatry; 1997 Sep; 154(9):1293-5. PubMed ID: 9286191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.